Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7437219rdf:typepubmed:Citationlld:pubmed
pubmed-article:7437219lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:7437219lifeskim:mentionsumls-concept:C0042276lld:lifeskim
pubmed-article:7437219lifeskim:mentionsumls-concept:C0027866lld:lifeskim
pubmed-article:7437219lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7437219pubmed:issue10lld:pubmed
pubmed-article:7437219pubmed:dateCreated1981-2-19lld:pubmed
pubmed-article:7437219pubmed:abstractTextThe ability of gallamine, metocurine, pancuronium, tubocurarine and atropine to block the response to postganglionic stimulation of the vagus nerve were measured in isolated, spontaneously beating guineapig atria. From analysis of the results in conjunction with those of earlier assays of concentrations that block effects of preganglionic vagal stimulation, it was concluded that only tubocurarine possessed ganglionic blocking activity. From calculation of the extent of block of muscarinic receptors at drug concentrations which blocked the response to postganglionic vagal stimulation, it was concluded that gallamine and pancuronium have an antivagal action exerted most probably on the postganglionic nerve terminal, and that this action is the most likely explanation of the tachycardia seen clinically with these two drugs.lld:pubmed
pubmed-article:7437219pubmed:languageenglld:pubmed
pubmed-article:7437219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7437219pubmed:citationSubsetIMlld:pubmed
pubmed-article:7437219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7437219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7437219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7437219pubmed:statusMEDLINElld:pubmed
pubmed-article:7437219pubmed:monthOctlld:pubmed
pubmed-article:7437219pubmed:issn0007-0912lld:pubmed
pubmed-article:7437219pubmed:authorpubmed-author:WattD ADAlld:pubmed
pubmed-article:7437219pubmed:authorpubmed-author:SonS LSLlld:pubmed
pubmed-article:7437219pubmed:issnTypePrintlld:pubmed
pubmed-article:7437219pubmed:volume52lld:pubmed
pubmed-article:7437219pubmed:ownerNLMlld:pubmed
pubmed-article:7437219pubmed:authorsCompleteYlld:pubmed
pubmed-article:7437219pubmed:pagination981-7lld:pubmed
pubmed-article:7437219pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:meshHeadingpubmed-meshheading:7437219-...lld:pubmed
pubmed-article:7437219pubmed:year1980lld:pubmed
pubmed-article:7437219pubmed:articleTitleEffects of non-depolarizing neuromuscular blocking agents on the cardiac vagus nerve in the guineapig.lld:pubmed
pubmed-article:7437219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7437219pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7437219pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed